Fingerprint Fingerprint is based on mining the text of the persons scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Neoplasms Medicine & Life Sciences
Colorectal Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
irinotecan Medicine & Life Sciences
Rectal Neoplasms Medicine & Life Sciences
Pancreatic Neoplasms Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Proteomics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2018

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer

Overman, M. J., Adam, L., Raghav, K., Wang, J., Kee, B., Fogelman, D., Eng, C., Vilar, E., Shroff, R., Dasari, A., Wolff, R., Morris, J., Karunasena, E., Pisanic, R., Azad, N. & Kopetz, S. Jan 1 2018 In : Annals of Oncology. 29, 1, p. 139-144 6 p., mdx688

Research output: Contribution to journalArticle

CpG Islands
Colorectal Neoplasms
Adenocarcinoma
Phenotype
Adenomatous Polyposis Coli

Academic cancer center phase i program development

Frankel, A. E., Flaherty, K. T., Weiner, G. J., Chen, R., Azad, N. S., Pishvaian, M. J., Thompson, J. A., Taylor, M. H., Mahadevan, D., Lockhart, A. C., Vaishampayan, U. N., Berlin, J. D., Smith, D. C., Sarantopoulos, J., Riese, M., Saleh, M. N., Ahn, C. & Frenkel, E. P. Apr 1 2017 In : Oncologist. 22, 4, p. 369-374 6 p.

Research output: Contribution to journalComment/debate

Program Development
Neoplasms
Research
Research Personnel
Clinical Trials

ACR Appropriateness Criteria ® Resectable Pancreatic Cancer

Jones, W. E., Suh, W. W., Abdel-Wahab, M., Abrams, R. A., Azad, N., Das, P., Dragovic, J., Goodman, K. A., Jabbour, S. K., Konski, A. A., Koong, A. C., Kumar, R., Lee, P., Pawlik, T. M., Small, W. & Herman, J. M. 2017 In : American Journal of Clinical Oncology: Cancer Clinical Trials. 40, 2, p. 109-117 9 p.

Research output: Contribution to journalReview article

Pancreatic Neoplasms
Adenocarcinoma
Guidelines
Expert Testimony
Adjuvant Chemotherapy

A final report of a phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis with a dose escalation in ovarian and fallopian tube cancers

Reiss, K. A., Herman, J. M., Armstrong, D., Zahurak, M., Fyles, A., Brade, A., Milosevic, M., Dawson, L. A., Scardina, A., Fischer, P., Hacker-Prietz, A., Kinders, R. J., Wang, L., Chen, A., Temkin, S., Horiba, N., Stayner, L. A., Siu, L. L. & Azad, N. S. Mar 1 2017 In : Gynecologic Oncology. 144, 3, p. 486-490 5 p.

Research output: Contribution to journalArticle

Fallopian Tube Neoplasms
Radiotherapy
Carcinoma
Neoplasms
Platinum

Combination epigenetic therapy in metastatic colorectal cancer (mCRC) with subcutaneous 5-azacitidine and entinostat; a phase 2 consortium/stand Up 2 cancer study

Azad, N. S. , El-Khoueiry, A. , Yin, J. , Oberg, A. L. , Flynn, P. , Adkins, D. , Sharma, A. , Weisenberger, D. J. , Brown, T. , Medvari, P. , Jones, P. A. , Easwaran, H. , Kamel, I. , Bahary, N. , Kim, G. , Picus, J. , Pitot, H. C. , Erlichman, C. , Donehower, R. , Shen, H. & 4 others Laird, P. W., Piekarz, R., Baylin, S. & Ahuja, N. 2017 In : Oncotarget. 8, 21, p. 35326-35338 13 p.

Research output: Contribution to journalArticle

Azacitidine
Epigenomics
Colorectal Neoplasms
Neoplasms
Therapeutics